C4 Therapeutics, Inc. - Common Stock (NQ: CCCC )
6.500
+0.060
(+0.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about C4 Therapeutics, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/12/13/image49.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/13/image44.jpg?width=1200&height=800&fit=crop)
US Stocks Mixed; Producer Prices Unchanged For November
December 13, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/12/13/clinical-trial-consulting-8344100_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for C4 Therapeutics
November 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/13/image23.jpeg?width=1200&height=800&fit=crop)
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 13, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/12/13/d.r._horton_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/12/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/12/johnson_controls_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/12/image39.jpeg?width=1200&height=800&fit=crop)
Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results
December 12, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2017/03/dealsmsn.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/shipping_containers_transportation_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/08/mrk-stock-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/12/image34_0.jpeg?width=1200&height=800&fit=crop)
US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November
December 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/12/cancel_cells.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 12, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/10/23/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
October 23, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Announces Chief Financial Officer Succession
September 05, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.